A global rank end point for clinical trials in acute heart failure.

Circulation. Heart failure

Volumn 3, Issue 5, 2010, Pages 643-646

  Felker, G Michael ^a   Maisel, Alan S ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE DISEASE; ARTICLE; BIOASSAY; CLINICAL TRIAL; HEART FAILURE; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY;

ACUTE DISEASE; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; HEART FAILURE; HUMANS; RESEARCH DESIGN;

MLCS; MLOWN;

EID: 77957902942     PISSN: None     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/circheartfailure.109.926030     Document Type: Article

References (0)